SBC (SBC Medical Group Holdings Incorporated Common Stock) Stock Analysis - Analyst Ratings

SBC Medical Group Holdings Incorporated Common Stock (SBC) is a publicly traded Industrials sector company. As of May 20, 2026, SBC trades at $3.02 with a market cap of $294.40M and a P/E ratio of 7.19. SBC moved +5.19% today. Year to date, SBC is -33.26%; over the trailing twelve months it is -15.25%. Its 52-week range spans $2.62 to $10.25. Analyst consensus is buy with an average price target of $8.50. Rallies surfaces SBC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SBC?

2 analysts cover SBC: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $8.50.

SBC Key Metrics

Key financial metrics for SBC
MetricValue
Price$3.02
Market Cap$294.40M
P/E Ratio7.19
EPS$0.40
Dividend Yield0.43%
52-Week High$10.25
52-Week Low$2.62
Volume81.37K
Avg Volume0
Revenue (TTM)$169.34M
Net Income$40.88M
Gross Margin70.80%

SBC Analyst Consensus

2 analysts cover SBC: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.50.

Latest SBC News

Recent SBC Insider Trades

  • Aikawa Yoshiyuki sold 465.00K (~$1.41M) on Apr 28, 2026.
  • Aikawa Yoshiyuki sold 3.10M (~$9.37M) on Apr 21, 2026.
  • Aikawa Yoshiyuki sold 4.42M (~$9.38M) on Mar 6, 2026.

Common questions about SBC

What do analysts rate SBC?
2 analysts cover SBC: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $8.50.
Does Rallies show SBC price targets?
Yes. Rallies tracks SBC analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SBC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SBC. It does not provide personalized investment advice.
SBC

SBC